165 related articles for article (PubMed ID: 31854033)
1. Renal Clearable Theranostic Nanoplatforms for Gastrointestinal Stromal Tumors.
Kang H; Stiles WR; Baek Y; Nomura S; Bao K; Hu S; Park GK; Jo MJ; I H; Coll JL; Rubin BP; Choi HS
Adv Mater; 2020 Feb; 32(6):e1905899. PubMed ID: 31854033
[TBL] [Abstract][Full Text] [Related]
2. Image-guided drug delivery of nanotheranostics for targeted lung cancer therapy.
Yin X; Cui Y; Kim RS; Stiles WR; Park SH; Wang H; Ma L; Chen L; Baek Y; Kashiwagi S; Bao K; Ulumben A; Fukuda T; Kang H; Choi HS
Theranostics; 2022; 12(9):4147-4162. PubMed ID: 35673583
[TBL] [Abstract][Full Text] [Related]
3. Preoperative imatinib treatment in patients with advanced gastrointestinal stromal tumors: patient experiences and systematic review of 563 patients.
Xu J; Ling TL; Wang M; Zhao WY; Cao H
Int Surg; 2015 May; 100(5):860-9. PubMed ID: 26011207
[TBL] [Abstract][Full Text] [Related]
4. A Giant Gastric Gastrointestinal Stromal Tumor Successfully Resected Following Neoadjuvant Treatment With Imatinib Mesylate.
Takahashi R; Toyokawa T; Yoshii M; Tamura T; Tanaka H; Lee S; Muguruma K; Yashiro M; Ohira M
Anticancer Res; 2020 Feb; 40(2):1147-1152. PubMed ID: 32014967
[TBL] [Abstract][Full Text] [Related]
5. Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST).
Tang S; Yin Y; Shen C; Chen J; Yin X; Zhang B; Yao Y; Yang J; Chen Z
World J Surg Oncol; 2017 Apr; 15(1):79. PubMed ID: 28399894
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected Intermediate- or High-Risk Primary Gastrointestinal Stromal Tumor: The PERSIST-5 Clinical Trial.
Raut CP; Espat NJ; Maki RG; Araujo DM; Trent J; Williams TF; Purkayastha DD; DeMatteo RP
JAMA Oncol; 2018 Dec; 4(12):e184060. PubMed ID: 30383140
[TBL] [Abstract][Full Text] [Related]
7. Is 3-years duration of adjuvant imatinib mesylate treatment sufficient for patients with high-risk gastrointestinal stromal tumor? A study based on long-term follow-up.
Lin JX; Chen QF; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang CM
J Cancer Res Clin Oncol; 2017 Apr; 143(4):727-734. PubMed ID: 28083710
[TBL] [Abstract][Full Text] [Related]
8. The Role of Surgery in Metastatic Gastrointestinal Stromal Tumors.
Keung EZ; Fairweather M; Raut CP
Curr Treat Options Oncol; 2016 Feb; 17(2):8. PubMed ID: 26820287
[TBL] [Abstract][Full Text] [Related]
9. A Novel Theranostic Combination of Near-infrared Fluorescence Imaging and Laser Irradiation Targeting c-KIT for Gastrointestinal Stromal Tumors.
Fujimoto S; Muguruma N; Okamoto K; Kurihara T; Sato Y; Miyamoto Y; Kitamura S; Miyamoto H; Taguchi T; Tsuneyama K; Takayama T
Theranostics; 2018; 8(9):2313-2328. PubMed ID: 29721082
[TBL] [Abstract][Full Text] [Related]
10. A Case of Disseminated Intra-abdominal Gastrointestinal Stromal Tumor Managed with Low Dose Imatinib.
Jang BH; Kim BW; Lim KJ; Kim BG; Park SM; Kim JS; Ji JS; Choi H
Korean J Gastroenterol; 2015 Jun; 65(6):366-9. PubMed ID: 26087692
[TBL] [Abstract][Full Text] [Related]
11. Tumor Penetrating Theranostic Nanoparticles for Enhancement of Targeted and Image-guided Drug Delivery into Peritoneal Tumors following Intraperitoneal Delivery.
Gao N; Bozeman EN; Qian W; Wang L; Chen H; Lipowska M; Staley CA; Wang YA; Mao H; Yang L
Theranostics; 2017; 7(6):1689-1704. PubMed ID: 28529645
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665.
Eisenberg BL; Harris J; Blanke CD; Demetri GD; Heinrich MC; Watson JC; Hoffman JP; Okuno S; Kane JM; von Mehren M
J Surg Oncol; 2009 Jan; 99(1):42-7. PubMed ID: 18942073
[TBL] [Abstract][Full Text] [Related]
13. [A Case of Rectal Gastrointestinal Stromal Tumor(GIST)Treated with Imatinib Mesylate Neoadjuvant Therapy to Preserve the Anus].
Kenno S; Inagaki M; Funakoshi T; Yanagida N; Akabane H; Nakano S; Sato K
Gan To Kagaku Ryoho; 2018 Jun; 45(6):981-984. PubMed ID: 30026427
[TBL] [Abstract][Full Text] [Related]
14. Can Imatinib Be Safely Withdrawn in Patients with Surgically Resected Metastatic GIST?
Hompland I; Bruland ØS
Anticancer Res; 2015 Nov; 35(11):5759-65. PubMed ID: 26503996
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal stromal tumor (GIST) with liver metastases: An 18-year experience from the GIST cooperation group in North China.
Shi YN; Li Y; Wang LP; Wang ZH; Liang XB; Liang H; Zhang L; Li B; Fan LQ; Zhao Q; Ma ZX; Zhao XF; Zhang ZD; Liu Y; Tan BB; Wang D; Wang LL; Hao YJ; Jia N
Medicine (Baltimore); 2017 Nov; 96(46):e8240. PubMed ID: 29145240
[TBL] [Abstract][Full Text] [Related]
16. [Targeted therapy combined with immunotherapy in gastrointestinal stromal tumor: a new era of hope and challenges].
Zhao W; Cao H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):966-971. PubMed ID: 28900984
[TBL] [Abstract][Full Text] [Related]
17. [A Case of Local Resection for Rectal GIST Following Neoadjuvant Imatinib Mesylate Treatment].
Yoshioka Y; Tokoro T; Ushijima H; Daito K; Kawamura J; Ueda K; Hida J; Okuno K
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1997-1999. PubMed ID: 29394846
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of different therapeutic modalities for rectal gastrointestinal stromal tumor: Summary of 14-year clinical experience in a single center.
Shu P; Sun XF; Fang Y; Gao XD; Hou YY; Shen KT; Qin J; Sun YH; Qin XY; Xue AW; Fu M
Int J Surg; 2020 May; 77():1-7. PubMed ID: 32173609
[TBL] [Abstract][Full Text] [Related]
19. Combined surgical and molecular therapy: the gastrointestinal stromal tumor model.
Gold JS; Dematteo RP
Ann Surg; 2006 Aug; 244(2):176-84. PubMed ID: 16858179
[TBL] [Abstract][Full Text] [Related]
20. [Successful resection of locally advanced gastrointestinal stromal tumor of the ampulla of Vater after treatment with imatinib].
Park JE; Dong SH; Cho KH; Jang JY; Kim HJ; Kim BH; Chang YW; Chang R
Korean J Gastroenterol; 2010 Jul; 56(1):39-44. PubMed ID: 20695129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
